Kevin E. Lofton - 03 May 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Kevin E. Lofton
Issuer symbol
GILD
Transactions as of
03 May 2022
Transactions value $
$0
Form type
4
Filing time
03 May 2022, 20:07:12 UTC
Previous filing
04 May 2022
Next filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2.22K +2.46% 92.7K 03 May 2022 By Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2.22K -18.44% 9.83K 03 May 2022 Common Stock 2.22K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 Includes 63,430 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust.
F3 100% of the restricted stock units vested on May 3, 2022.